Mesa Laboratories (MLAB) EBT (2010 - 2026)

Mesa Laboratories has disclosed EBT across 17 years of filings, most recently posting $4.4 million for Q2 2026.

• In Q2 2026, EBT fell 37.92% year-over-year to $4.4 million; the TTM figure through Jun 2026 stood at $9.4 million (up 3.16% YoY), while the FY2026 annual figure was $12.0 million, up 101.54% from the prior year.
• EBT came in at $4.4 million for Q2 2026 at Mesa Laboratories, up from -$1.6 million in the prior quarter.
• In the past five years, EBT ranged from a high of $7.0 million in Q2 2025 to a low of -$275.3 million in Q1 2024.
• Average EBT over 5 years is -$14.1 million, with a median of $1.2 million recorded in 2022.
• The largest YoY upside for EBT was 516.76% in 2024 against a maximum downside of 99297.83% in 2024.
• Over 5 years, EBT stood at $1.9 million in 2022, then grew by 1.57% to $1.9 million in 2023, then sank by 213.93% to -$2.2 million in 2024, then soared by 307.31% to $4.6 million in 2025, then decreased by 5.29% to $4.4 million in 2026.
• Per Business Quant data, the three most recent EBT figures were $4.4 million in Q2 2026, -$1.6 million in Q1 2026, and $4.6 million in Q4 2025.